[{"NetIncomeLoss_2_Q2_USD":-46915000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":993600.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":21.78,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":134852000.0,"Depreciation_1_Q2_USD":200000.0,"Depreciation_2_Q2_USD":400000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-120784000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet_2_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":17541000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-184000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_0_Q2_USD":17.54,"AccruedLiabilitiesCurrent_0_Q2_USD":6931000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":75000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":53968405.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":52163136.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-80000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":10697000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-69000.0,"AssetsCurrent_0_Q2_USD":241261000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":15.96,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0,"DisposalGroupIncludingDiscontinuedOperationAccountsPayableCurrent_0_Q2_USD":936000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0,"LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_0_Q2_USD":3094000.0,"ShareBasedCompensation_2_Q2_USD":6507000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_0_Q2_USD":17.51,"NetRentableArea_0_Q2_sqft":33019.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-44000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-90000.0,"Assets_0_Q2_USD":288046000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":152730000.0,"CommonStockSharesIssued_0_Q2_shares":61204987.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":5237341.0,"LongTermDebt_0_Q2_USD":10731000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":15000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":5870000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OperatingLeaseLiability_0_Q2_USD":3206000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":7380000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":535000.0,"StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_1_Q2_USD":1041000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":34503000.0,"CommonStockValue_0_Q2_USD":1000.0,"NumberOfReportableSegments_2_Q2_segment":2.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.766,"AccountsReceivableNetCurrent_0_Q2_USD":939000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-155000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-380000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":861000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_0_Q2_shares":2044235.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q2_USD":75000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":294000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":17.54,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":236621000.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q2_USD":0.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q2_USD":4800000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_2_Q2_USD":21239000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-10000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":25000.0,"Liabilities_0_Q2_USD":54231000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":2559000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":113447000.0,"OtherAssetsNoncurrent_0_Q2_USD":3909000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0091,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":5223000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1290000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-47005000.0,"IncomeLossFromContinuingOperations_1_Q2_USD":-18161000.0,"IncomeLossFromContinuingOperations_2_Q2_USD":-46915000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":266200000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":26557000.0,"CostsAndExpenses_1_Q2_USD":19830000.0,"CostsAndExpenses_2_Q2_USD":50136000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-18205000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":15735000.0,"DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent_0_Q2_USD":2158000.0,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"LiabilitiesCurrent_0_Q2_USD":14916000.0,"CostOfRevenue_2_Q2_USD":2465000.0,"CostOfRevenue_1_Q2_USD":1263000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-24453000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-69000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":3833000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":3038000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":7000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":3042000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":75000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_0_Q2_shares":3738625.0,"FederalIncomeTaxExpenseBenefitContinuingOperations_2_Q2_USD":0.0,"FederalIncomeTaxExpenseBenefitContinuingOperations_1_Q2_USD":0.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":147289000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":75000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_0_Q2_USD":10090000.0,"CommonStockSharesOutstanding_0_Q2_shares":61204987.0,"AccountsPayableCurrent_0_Q2_USD":4244000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":8648000.0,"NetIncomeLoss_1_Q2_USD":-18161000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1287000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q2_USD":25300000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_2_Q2_USD":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax_1_Q2_USD":0.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":37000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":367000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":457000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":115548.0,"AdditionalPaidInCapital_0_Q2_USD":785455000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_0_Q2_USD":17541000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":7086000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":1230000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":1459000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":113447000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":167000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":91384000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-551457000.0,"DividendsPayableCurrentAndNoncurrent_0_Q2_USD":0.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":1922000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":288046000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":12.63,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":23.88,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":0.0,"SaleOfStockConsiderationReceivedOnTransaction_2_Q2_USD":238200000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":1373000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":118227000.0,"OperatingIncomeLoss_2_Q2_USD":-46535000.0,"OperatingIncomeLoss_1_Q2_USD":-18006000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":3601000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":1824000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":6507000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":3832000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":16700000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":10925.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":3738625.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":152738000.0,"LossContingencyAccrualCarryingValueCurrent_0_Q2_USD":3075000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":52000.0,"StockholdersEquity_0_Q2_USD":233815000.0,"OtherLiabilitiesCurrent_0_Q2_USD":647000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":2917000.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q2_USD":0.0,"ProfitLoss_2_Q2_USD":-46915000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.9,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_0_Q2_USD":16700000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":37000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":647000.0,"StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_2_Q2_USD":0.0,"StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_1_Q2_USD":0.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":4329000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.34,"ResearchAndDevelopmentExpense_1_Q2_USD":7897000.0,"Ticker":"ACRS","CIK":"1557746","name":"ACLARIS THERAPEUTICS, INC.","OfficialName":"Aclaris Therapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"2","uom":"USD","footnote":"nan","Market Cap":"1075670582.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]